Monoclonal antibody approved for treatment of Crohn's disease.

T. R. Freeman; P. Piascik

doi:10.1016/S1086-5802(16)30406-5

Monoclonal antibody approved for treatment of Crohn's disease.

T. R. Freeman, P. Piascik

Pharmacy Practice and Science

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	770-772
Number of pages	3
Journal	Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volume	38
Issue number	6
DOIs	https://doi.org/10.1016/S1086-5802(16)30406-5
State	Published - 1998

Bibliographical note

Funding Information:
is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

Funding

is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

Funders	Funder number
AMGen
University of Kentucky

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.1016/S1086-5802(16)30406-5

Cite this

@article{e81904d6da5945de87a5e62690811208,

title = "Monoclonal antibody approved for treatment of Crohn's disease.",

author = "Freeman, \{T. R.\} and P. Piascik",

note = "Funding Information: is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac\textasciitilde{}andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.",

year = "1998",

doi = "10.1016/S1086-5802(16)30406-5",

language = "English",

volume = "38",

pages = "770--772",

number = "6",

}

TY - JOUR

T1 - Monoclonal antibody approved for treatment of Crohn's disease.

AU - Freeman, T. R.

AU - Piascik, P.

N1 - Funding Information: is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=0032199532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032199532&partnerID=8YFLogxK

U2 - 10.1016/S1086-5802(16)30406-5

DO - 10.1016/S1086-5802(16)30406-5

M3 - Article

C2 - 9861797

AN - SCOPUS:0032199532

SN - 1086-5802

VL - 38

SP - 770

EP - 772

JO - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

JF - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

IS - 6

ER -

Monoclonal antibody approved for treatment of Crohn's disease.

Bibliographical note

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this